Aurobindo

Activities: Ingredients

Trending Articles

  1. Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms
  2. Amgen invests $1bn into new US drug manufacturing facility The site will be the CDMO's second drug substance manufacturing facility in North Carolina, and will boost its presence in the US pharmaceutical market
  3. Reckitt expands US OTC manufacturing footprint with North Carolina facility The site in Wilson will be responsible for producing Mucinex® branded tablets and liquids, which are designed as over the counter (OTC) medicines for cold and flu symptoms
  4. Precision psychiatry in action: How IMed Consultancy helped HMNC Brain Health’s Cortibon programme AI-driven approach promises a new class of depression treatment
  5. Pharma Packaging and Labelling Forum 27–28 May 2025 | Conference | Basel, Switzerland

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Manufacturing

Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company

The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
Pharmaceutical

Indian pharma firms develop niche portfolios

They aim to take advantage of generic growth in the US over the next two years
Pharmaceutical

Indian generic manufacturers aim to enter the Japanese market

The penetration of generic drugs in Japan is a little more than 30% compared with more 80% in the US market
Media

Aurobindo's generic drug for osteoporosis approved by US FDA

The global osteoporosis drugs market is seeing significant growth due to a rising geriatric population and changing lifestyles
Finance

Aurobindo and Glenmark to get inflow of foreign capital

Deals underscore the importance given by the Indian government to strengthening healthcare in the country, by ensuring availability of drugs to the population at reasonable prices
Finance

Aurobindo divests stake in Australian subsidiary

Company also reaches settlement with Plethico over Natrol acquisition
Regulatory

Nearly 90,000 Gabapentin capsules are recalled by Aurobindo Pharma and Actavis

The capsules were manufactured at two plants in India
Subscribe now